Patient Square Capital’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
Patient Square Capital's CGEM Position: Q3 2025 in Review
Patient Square Capital sold out of Cullinan Therapeutics (CGEM) in Q3 2025, closing a stake of 868,897 shares — an estimated $6.54M sold.
Patient Square Capital first reported a position in CGEM in Q3 2024 and held it in 4 quarters. The position peaked at $13.8M in Q3 2024. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.
- Patient Square Capital reported no remaining Cullinan Therapeutics position as of Q3 2025 after selling out during the quarter.
- Patient Square Capital sold 868,897 Cullinan Therapeutics shares in Q3 2025, an estimated $6.54M.
- Patient Square Capital first reported a position in Cullinan Therapeutics in Q3 2024 and held it in 4 quarters.
- Patient Square Capital's Cullinan Therapeutics position peaked at $13.8M in Q3 2024.
- 145 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2025.
Based on Patient Square Capital's 13F filing for Q3 2025, filed 10 Nov 2025.